Skip to content
Search

Latest Stories

OneWeb launches 34 new satellites, increases tally to 288

OneWeb launches 34 new satellites, increases tally to 288

BRITISH space internet company OneWeb has successfully launched 34 new satellites into space on Saturday (21) through Russian Soyuz rocket, taking its in-orbit mega-constellation to 288.

The rocket operated by Europe's Arianespace took off successfully at 2213 GMT Saturday (21) from the Baikonur cosmodrome in Kazakhstan, the Roscosmos space agency said in a statement.


This marked the fifth launch of OneWeb satellites this year, with the last one on July 1.

OneWeb is working to complete the construction of a constellation of low earth orbit satellites and planning to provide enhanced broadband and other services to countries worldwide.

It aims to make the global commercial internet service operational by next year.

Arianespace, which has worked with Russia for close to two decades, is under contract to make 16 Soyuz launches between December 2020 and the end of 2022.

Last year, Indian conglomerate Bharti Global along with the British government rescued OneWeb out of banckruptcy, each putting $500 million (£400m) into the struggling firm.

Since then, other investors have also joined the project.

In July, Bharti Global’s announced to inject $500m (£362m) into the ventures that will complete the necessary financing to roll out the remainder of the mega-constellation.

OneWeb is competing against billionaires Elon Musk and Jeff Bezos in the race to provide fast internet for the world's remote areas via satellites.

More For You

pharmaceuticals

UK becomes the only country in the world to have secured a zero per cent tariff rate for pharmaceutical shipments

iStock

UK secures zero-tariff deal with US on pharmaceuticals

Highlights

  • UK pharmaceutical exports worth £5bn annually protected from US tariffs for three years.
  • NHS spending on medicines to double from 0.3 per cent to 0.6 per cent of GDP over next decade.
  • Deal safeguards jobs at major British drugmakers including GSK and AstraZeneca.
The UK has secured a landmark deal with the United States guaranteeing zero tariffs on pharmaceutical exports. The UK government said it was the only country in the world to have secured a zero per cent tariff rate for pharmaceutical shipments.

Under the agreement announced on Monday, the NHS will pay more for medicines in return for a three-year guarantee that US import taxes on pharmaceuticals made in Britain will remain at zero per cent.

The deal comes after US President Donald Trump threatened to raise tariffs to as high as 100 per cent on branded drug imports, raising alarm for major British drugmakers including GSK and AstraZeneca.

Keep ReadingShow less